pharma · Crohn's Disease · Ulcerative Colitis (UC)
AbbVie
AbbVie is a pharma organization headquartered in Hamilton, CN. Primary therapeutic focus areas include Crohn's Disease, Ulcerative Colitis (UC), Psoriatic Arthritis, Rheumatoid Arthritis, Hidradenitis Suppurativa. NovaPh
1 Waukegan Road, North Chicago, Illinois 60064, US HQ
60,084 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 1 Waukegan Road, North Chicago, Illinois 60064, US
- Employees
- 60,084
- Programs
- 41
- Drugs
- 32
- Patents
- 25
Glecaprevir/Pibrentasvir
Phase 3 · small molecule · Hepatitis C Virus (HCV)
Glecaprevir/Pibrentasvir for Hepatitis C Virus (HCV) is a Phase 3 program (small_molecule) at AbbVie with 2 ClinicalTrials.gov record(s).
Internal code M16-126
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AbbVie
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Hepatitis C Virus (HCV)
- Status
- completed
- Trials
- 2